Trials / Sponsors / HiFiBiO Therapeutics
HiFiBiO Therapeutics
Industry · 5 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | A Study of HFB200603 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced So Renal Cell Carcinoma, Melanoma, Non Small Cell Lung Cancer | Phase 1 | 2023-05-09 |
| Terminated | A Study of HFB301001 in Adult Patients With Advanced Solid Tumors Soft Tissue Sarcoma, Renal Cell Carcinoma, Uterine Carcinosarcoma | Phase 1 | 2022-04-20 |
| Active Not Recruiting | A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced So Gastric Cancer, Renal Cell Carcinoma, Melanoma | Phase 1 | 2022-03-10 |
| Completed | A Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Chinese Heal Healthy | Phase 1 | 2021-05-09 |
| Completed | Study to Assess the Safety, Tolerability, and Pharmacokinetics of HFB30132A Against COVID-19 in Healthy Adults Healthy | Phase 1 | 2020-10-20 |